These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 17724816)

  • 21. Cancer Metabolism as a Mechanism of Treatment Resistance and Potential Therapeutic Target in Hepatocellular Carcinoma.
    Lee M; Ko H; Yun M
    Yonsei Med J; 2018 Dec; 59(10):1143-1149. PubMed ID: 30450847
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differentiation of malignant thrombus from bland thrombus of the portal vein in patients with hepatocellular carcinoma: application of diffusion-weighted MR imaging.
    Catalano OA; Choy G; Zhu A; Hahn PF; Sahani DV
    Radiology; 2010 Jan; 254(1):154-62. PubMed ID: 20032150
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Portal venous tumor growth-type of hepatocellular carcinoma without liver parenchyma tumor nodules: a case report.
    Saito M; Seo Y; Yano Y; Uehara K; Hara S; Momose K; Hirano H; Yokozaki H; Yoshida M; Azuma T
    Ann Hepatol; 2013; 12(6):969-73. PubMed ID: 24114829
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of 18F-FDG accumulation and arterial enhancement as biomarkers in the assessment of typing, grading and staging of hepatocellular carcinoma using 18F-FDG-PET/CT with integrated dual-phase CT angiography.
    Ferda J; Ferdová E; Baxa J; Kreuzberg B; Daum O; Třeška V; Skalický T
    Anticancer Res; 2015 Apr; 35(4):2241-6. PubMed ID: 25862885
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationship between SUVmax on 18F-FDG PET and PD-L1 expression in hepatocellular carcinoma.
    Zhou X; Hu Y; Sun H; Chen R; Huang G; Liu J
    Eur J Nucl Med Mol Imaging; 2023 Aug; 50(10):3107-3115. PubMed ID: 37147479
    [TBL] [Abstract][Full Text] [Related]  

  • 26. FDG PET for discrimination between tumor extension and blood thrombus as a cause for portal vein thrombosis in hepatocellular carcinoma: important role in exclusion of transplant candidacy.
    Kurtovic J; Van Der Wall H; Riordan SM
    Clin Nucl Med; 2005 Jun; 30(6):408-10. PubMed ID: 15891293
    [No Abstract]   [Full Text] [Related]  

  • 27. Usefulness 18F-FDG positron emission tomography/computed tomography for detecting recurrence of hepatocellular carcinoma in posttransplant patients.
    Kim YK; Lee KW; Cho SY; Han SS; Kim SH; Kim SK; Park SJ
    Liver Transpl; 2010 Jun; 16(6):767-72. PubMed ID: 20517911
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatocellular carcinoma presenting as an incidental isolated malignant portal vein thrombosis.
    Poddar N; Avezbakiyev B; He Z; Jiang M; Gohari A; Wang JC
    J Gastrointest Cancer; 2012 Sep; 43(3):486-9. PubMed ID: 21190093
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The predictive value of metabolic tumor volume on FDG PET/CT for transarterial chemoembolization and transarterial chemotherapy infusion in hepatocellular carcinoma patients without extrahepatic metastasis.
    Lee JW; Yun M; Cho A; Han KH; Kim DY; Lee SM; Lee JD
    Ann Nucl Med; 2015 Jun; 29(5):400-8. PubMed ID: 25652647
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Growth velocity of the portal vein tumor thrombus accelerated by its progression, alpha-fetoprotein level, and liver fibrosis stage in patients with hepatocellular carcinoma.
    Gon H; Kido M; Tanaka M; Kinoshita H; Komatsu S; Tsugawa D; Awazu M; Toyama H; Matsumoto I; Itoh T; Fukumoto T
    Surgery; 2018 Nov; 164(5):1014-1022. PubMed ID: 30093272
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumor thrombus: ancillary findings on FDG PET/CT in an oncologic population.
    Ravina M; Hess S; Chauhan MS; Jacob MJ; Alavi A
    Clin Nucl Med; 2014 Sep; 39(9):767-71. PubMed ID: 24999677
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of three-dimensional imaging in optimizing diagnosis, classification and surgical treatment of hepatocellular carcinoma with portal vein tumor thrombus.
    Wei XB; Xu J; Li N; Yu Y; Shi J; Guo WX; Cheng HY; Wu MC; Lau WY; Cheng SQ
    HPB (Oxford); 2016 Mar; 18(3):287-95. PubMed ID: 27017169
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CT findings of completely regressed hepatocellular carcinoma with main portal vein tumor thrombosis after transcatheter arterial chemoembolization.
    Yoon JH; Kim HC; Chung JW; Yoon JH; Jae HJ; Park JH
    Korean J Radiol; 2010; 11(1):69-74. PubMed ID: 20046497
    [TBL] [Abstract][Full Text] [Related]  

  • 34. FDG PET/CT Imaging of Hepatocellular Carcinoma With Bile Duct Tumor Thrombus.
    Zhang W; Fang C; Liu H; Chen Y
    Clin Nucl Med; 2019 Feb; 44(2):130-132. PubMed ID: 30562190
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Hepatocarcinoma invasion of the portal vein: detection using lipiodol computed tomography. Apropos of 2 cases].
    Soyer P; Chacroun K; Pelage JP; Boudiaf M; Rymer R
    J Radiol; 1999 Jan; 80(1):47-9. PubMed ID: 10052038
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatocellular carcinoma with main portal vein tumor thrombus: a comparative study comparing hepatectomy with or without neoadjuvant radiotherapy.
    Li N; Feng S; Xue J; Wei XB; Shi J; Guo WX; Lau WY; Wu MC; Cheng SQ; Meng Y
    HPB (Oxford); 2016 Jun; 18(6):549-56. PubMed ID: 27317960
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Emerging role of
    Lee SM; Kim HS; Lee S; Lee JW
    World J Gastroenterol; 2019 Mar; 25(11):1289-1306. PubMed ID: 30918424
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic factors for hepatocellular carcinoma presenting with macroscopic portal vein tumor thrombus.
    Sakata H; Konishi M; Ryu M; Kinoshita T; Satake M; Moriyama N; Ochiai T
    Hepatogastroenterology; 2004; 51(60):1575-80. PubMed ID: 15532781
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A prospective evaluation of 18F-FDG and 11C-acetate PET/CT for detection of primary and metastatic hepatocellular carcinoma.
    Park JW; Kim JH; Kim SK; Kang KW; Park KW; Choi JI; Lee WJ; Kim CM; Nam BH
    J Nucl Med; 2008 Dec; 49(12):1912-21. PubMed ID: 18997056
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dual-tracer PET/CT imaging in evaluation of metastatic hepatocellular carcinoma.
    Ho CL; Chen S; Yeung DW; Cheng TK
    J Nucl Med; 2007 Jun; 48(6):902-9. PubMed ID: 17504862
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.